Journal article
Advancing clinical research globally: Cervical cancer research network from Mexico
BJ Ager, D Gallardo-Rincón, DC de León, A Chávez-Blanco, L Chuang, A Dueñas-González, E Gómez-García, R Jerez, A Jhingran, M McCormack, L Mileshkin, C Pérez-Plasencia, M Plante, A Poveda, DK Gaffney
Gynecologic Oncology Reports | ELSEVIER SCIENCE INC | Published : 2018
Abstract
Cervical cancer is the fourth most common cancer in women with 85% of the mortality burden occurring in less-developed regions of the world. The Cervix Cancer Research Network (CCRN) was founded by the Gynecologic Cancer InterGroup (GCIG) with a mission to improve outcomes in cervix cancer by increasing access to high-quality clinical trials worldwide, with particular attention to less-developed, underrepresented sites. The CCRN held its second international educational symposium in Mexico City with ninety participants from fifteen Latin America countries in January 2017. The purpose of this symposium was to advance knowledge in cervix cancer therapy, promote recruitment to CCRN clinical tri..
View full abstractGrants
Funding Acknowledgements
The authors would like to acknowledge the following sponsors for their continued support of the CCRN mission and its clinical trials: Varian, Elekta-Nucletron, Zeria, Advaxis, GICOM, Roche Mex, and AZ Mex.